TherapeuticsMD
TXMD
TXMD
128 hedge funds and large institutions have $973M invested in TherapeuticsMD in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 66 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+5
Holders Change %
+4.07%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
66
Reduced
26
Closed
15
Calls
$3.4M
Puts
$1.76M
Net Calls
+$1.64M
Net Calls Change
-$12.4M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$67.1M |
| 2 |
JPMorgan Chase & Co
New York
|
+$24M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.9M |
| 5 |
Bank of New York Mellon
New York
|
+$7.47M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$5.49M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$5.28M |
| 3 |
Millennium Management
New York
|
-$4.55M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.77M |
| 5 |
AI
Analytic Investors
Los Angeles,
California
|
-$1.49M |
